TOP PAGE
ENGLISH
JAPANESE
|
CONNECT WITH US:
Home
About
Services
Contact
Log in
*
Home
Press release
Mar 31, 2021 13:41 JST
Source:
Toyota Motor Corporation
Japanese Red Cross Kumamoto Hospital and Toyota to Begin Utilization Demonstration of the World's First Fuel Cell Electric Vehicle Mobile Clinic
Promoting Use of Hydrogen to Achieve Carbon Neutrality and Contributing to Disaster Response
Toyota City, Japan, Mar 31, 2021 - (JCN Newswire) - Japanese Red Cross Kumamoto Hospital and Toyota Motor Corporation (Toyota) have agreed to begin demonstration testing of the world's first(1) fuel cell electric vehicle mobile clinic (FCEV mobile clinic) that uses hydrogen to generate electricity, by the summer of 2021. The organizations aim to use this demonstration testing to confirm the effectiveness of a commercial fuel cell electric vehicle (FCEV) in areas of medicine and disaster countermeasures, and to achieve carbon neutrality. By building an operational model of an FCEV mobile clinic for utilization during normal times and times of disaster, they will also contribute to the reduction of CO2 emissions to help prevent global warming.
Typhoons, heavy rains and other natural disasters have increased in frequency over recent years, causing not only power outages for homes and evacuation centers, but also increasing the need for medical services in disaster-affected areas. In light of this, Toyota has been working with Japanese Red Cross Kumamoto Hospital since around the summer of 2020 to look into how these issues could be addressed. As a result, the two organizations have agreed to contribute to solving issues associated with natural disasters. This would be achieved with an FCEV mobile clinic that could be used to deliver medical services during normal times, and could also be used to support disaster relief efforts during times of disaster, while supplying electricity in disaster-affected areas as part of a disaster response.
Toyota has developed the FCEV mobile clinic based on its Coaster minibus, with the power source using the Toyota fuel cell system(2) employed by the "Mirai" FCEV. On the road, it exhibits a superior environmental performance with no CO2 emissions or substances of concern (SoC), while offering a low-noise, low-vibration driving experience.
With multiple 100 VAC accessory power outlets supplied not only inside the vehicle but also outside the cabin, the vehicle is able to supply electricity to a variety of electrical products. It is also equipped with an external DC electric power supply system that delivers a high-output, large-capacity supply of power(3) (9 kW max output, approx. 90 kWh supply capacity). Inside, the vehicle combines air conditioning with an exhaust system and HEPA filter(4) to improve infection control for occupants when working.
Japanese Red Cross Kumamoto Hospital and Toyota believe the FCEV mobile clinic has the ability to create new value not found in conventional mobile clinics. Bringing their respective knowledge and technologies to the development. and utilizing the exceptional environmental performance that is unique to FCEVs, they aim to explore expanded applications for a mobile clinic that can reduce stress levels for both medical staff and patients. Demonstration testing seeks to achieve a reassuring power supply during times of disaster with a view to effective utilization of the vehicle's power supply capabilities in medical settings and disaster-affected areas. In addition to emergency transportation of patients, they believe the FCEV mobile clinic has the potential for a wide range of applications and developments in the healthcare field, including supplying electricity to blood donation buses and medical examination vehicles, traveling to less-populated areas as a mobile clinic, and a mobile PCR testing vehicle.
(1) As of March 2021, according to Toyota Motor Corporation.
(2) Fuel cell system installed in the first-generation Mirai.
(3) The power that can be supplied and the power amount may differ, depending on the performance of the power supply unit, amount of hydrogen remaining, and power consumption. External power feeding devices are sold separately.
(4) HEPA stands for high-efficiency particulate air (filter). According to JIS standards, HEPA filters are defined as having a particle capture rate of at least 99.97% of particles measuring 0.3 μm in diameter at a rated air flow, and an initial pressure loss of 245 Pa or less.
Source: Toyota Motor Corporation
Sectors: Automotive
Copyright ©2026 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Related Press Release
Premiere of Three-Row Highlander BEV in North America
February 11 2026 13:25 JST
The 55-Point Gap: Measuring What Matters in Automotive Impact
February 04 2026 17:00 JST
TOYOTA GAZOO Racing Announces GR Yaris Sebastien Ogier 9x World Champion Edition
January 23 2026 18:26 JST
New-look TGR-WRT launches landmark campaign on legendary rally
January 16 2026 20:34 JST
TOYOTA GAZOO Racing Announces GR Yaris MORIZO RR
January 09 2026 15:03 JST
TOYOTA GAZOO Racing Reverting to "GAZOO Racing" to Pass on and Evolve the Making of Ever-better Cars and the Fostering of Talent
January 07 2026 21:04 JST
Toyota's European R&D center changes its name and competes in WEC with a new brand
January 07 2026 20:50 JST
Toward an Athlete- and Planet-Friendly Hakone Ekiden: All Vehicles Provided for the 2026 Race Will Be Electrified
December 23 2025 02:18 JST
Lexus World Premieres Lexus LFA Concept BEV Sports Car
December 05 2025 18:13 JST
TOYOTA GAZOO Racing World Premieres GR GT & GR GT3
December 05 2025 17:58 JST
More Press release >>
Latest Press Release
Fujitsu and 1Finity to highlight latest network technologies and AI solutions at MWC Barcelona 2026
Feb 13, 2026 22:50 JST
Fujitsu to present latest technologies for creating social and industrial value through fusion of AI and computing at India AI Impact Summit 2026
Feb 13, 2026 22:33 JST
Mitsubishi Power Hosts Inaugural Energy Forward Forum in Indonesia with Government and Industry Experts
Feb 13, 2026 22:24 JST
MHI Successfully Demonstrates Production of Liquid Synthetic Fuels through an integrated Process Utilizing SOEC Co-Electrolysis and FT Synthesis
Feb 13, 2026 22:03 JST
JCB Sponsors the NHK Symphony Orchestra Singapore Concert 2026 - Celebrating 60 Years of Singapore-Japan Relations
Feb 13, 2026 14:00 JST
Lockheed Martin and Fujitsu Formalize Industrial Collaboration for Japan Defense
Feb 12, 2026 19:59 JST
Meiji and Fujitsu launch world's first rRAFU(TM) pilot to assess future malnutrition and frailty risk
Feb 12, 2026 16:09 JST
Fujitsu Group starts manufacturing sovereign AI servers in Japan to enhance digital sovereignty
Feb 12, 2026 12:13 JST
Premiere of Three-Row Highlander BEV in North America
Feb 11, 2026 14:25 JST
Honda Works Partner Aston Martin Aramco Formula One(TM) Team Unveils Livery of "AMR26" F1(TM) Machine Equipped with Honda Power Unit Ahead of the 2026 Race Season
Feb 10, 2026 18:25 JST
Honda to Make Organizational Changes to Further Enhance Competitiveness its Motorcycle, Automobile and Power Products Business
Feb 10, 2026 17:53 JST
KS Energy and Hitachi Collaborate on Extra-High Voltage Battery Energy Storage System
Feb 10, 2026 14:15 JST
Biologics License Application for Subcutaneous Formulation of "LEQEMBI(R)" (lecanemab) for the Treatment of Early Alzheimer's Disease Designated for Priority Review in China
Feb 10, 2026 13:34 JST
NEC Exhibits at MWC Barcelona 2026, the World's Largest Mobile-Related Exhibition
Feb 09, 2026 21:18 JST
CITIC Telecom CPC Wins Two Awards, Celebrating 'Innovation Never Stops' for 25 Years, recognizing Cybersecurity & Innovation Excellence
Feb 09, 2026 14:28 JST
JCB Announces Collaboration with Resorts World Sentosa in Singapore
Feb 09, 2026 14:00 JST
Anime Tokyo Station: "That Time I Got Reincarnated as a Slime" Special Exhibition, February 21 to May 24, 2026
Feb 09, 2026 11:00 JST
Mitsubishi Motors Launches the All-New Versa Van in the Philippine Market
Feb 06, 2026 13:34 JST
Establishment of the World's First*1 Global Supply Chain to Introduce the Use of Renewable Plastics in Sony's High-Performance Products
Feb 06, 2026 11:50 JST
Eisai and Henlius Enter into Exclusive Commercial License Agreement for Anti-PD-1 Antibody Serplulimab in Japan
Feb 06, 2026 11:31 JST
More Latest Release >>